admilparant (BMS-986278) / BMS 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
12 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
admilparant (BMS-986278) / BMS
NCT06003426: A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

Recruiting
3
1185
Europe, Canada, Japan, US, RoW
BMS-986278, Admilparant, BMS-986278 Placebo
Bristol-Myers Squibb
Idiopathic Pulmonary Fibrosis
10/26
10/26
NCT06025578: A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

Recruiting
3
1092
Europe, Canada, Japan, US, RoW
BMS-986278, BMS-986278 Placebo
Bristol-Myers Squibb
Progressive Pulmonary Fibrosis
12/27
12/27
NCT04308681 / 2019-003992-21: A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis

Completed
2
403
Europe, Canada, Japan, US, RoW
BMS-986278 Placebo, BMS-986278
Bristol-Myers Squibb
Pulmonary Fibrosis
08/22
09/23
NCT05684289: A Study Investigating the Safety, Tolerability, Drug Levels and Drug Effect of BMS-986278 in Healthy Adult Participants (Part 1) and Japanese Participants (Part 2)

Completed
1
61
US
BMS-986278, Sildenafil, Placebo
Bristol-Myers Squibb
Healthy Participants
05/23
05/23
NCT05805904: A Study to Evaluate the Drug Levels, Safety, and Tolerability of BMS-986278 in Healthy Chinese Participants

Completed
1
24
RoW
BMS-986278, Placebo
Bristol-Myers Squibb
Healthy Volunteers
05/23
05/23
NCT05932303: A Study to Assess the Effect of Multiple Doses of Itraconazole, Gemfibrozil, or Carbamazepine on BMS-986278 in Healthy Participants

Completed
1
47
Canada
BMS-986278, Itraconazole, Gemfibrozil, Carbamazepine
Bristol-Myers Squibb
Healthy Participants
10/23
10/23
NCT05985590: A Study to Investigate the Effects of BMS-986278 on Drospirenone and Ethinyl Estradiol Drug Levels in Healthy Female Participants

Completed
1
37
Canada
BMS-986278, Drospirenone/Ethinyl Estradiol
Bristol-Myers Squibb
Healthy Volunteers
12/23
12/23
NCT06425198: Study to Assess Drug Levels and Safety of BMS-986278 in Healthy Participants and Participants With Different Degrees of Hepatic Impairment

Recruiting
1
48
US
BMS-986278
Bristol-Myers Squibb
Hepatic Impairment, Healthy Participants
12/24
12/24
NCT06568458: A Study to Assess the Extent of Drug Interaction Between BMS-986278 and Nintedanib, the Relative Bioavailability of BMS-986278 in Tablet and the Effect That Food Has on BMS-986278 in Tablet Formulations in Healthy Participants

Completed
1
71
US
Nintedanib, BMS 986278
Bristol-Myers Squibb
Healthy Participants
02/25
02/25
NCT06723535: A Study to Evaluate BMS-986278 in Participants With Normal Renal Function, Severe Renal Impairment, or End-Stage Renal Disease on Intermittent Hemodialysis

Recruiting
1
32
US
BMS-986278
Bristol-Myers Squibb
Kidney Failure, Chronic, Healthy Volunteers, Renal Impairment
10/25
10/25
NCT06715683: A Study to Evaluate Comparative Bioavailability of BMS-986278 in Healthy Participants

Completed
1
48
US
BMS-986278 Batched method, Dose A, BMS-986278 Batched method, Dose B, BMS-986278 Continuous method
Bristol-Myers Squibb
Healthy Volunteers
03/25
03/25
NCT06746402: A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of BMS-986278 and the Effects of BMS-986278 on Cardiac Repolarization in Healthy Participants

Recruiting
1
42
US
BMS-986278, Placebo, Moxifloxacin
Bristol-Myers Squibb
Healthy Volunteers
09/25
09/25
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
admilparant (BMS-986278) / BMS
NCT06003426: A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

Recruiting
3
1185
Europe, Canada, Japan, US, RoW
BMS-986278, Admilparant, BMS-986278 Placebo
Bristol-Myers Squibb
Idiopathic Pulmonary Fibrosis
10/26
10/26
NCT06025578: A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

Recruiting
3
1092
Europe, Canada, Japan, US, RoW
BMS-986278, BMS-986278 Placebo
Bristol-Myers Squibb
Progressive Pulmonary Fibrosis
12/27
12/27
NCT04308681 / 2019-003992-21: A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis

Completed
2
403
Europe, Canada, Japan, US, RoW
BMS-986278 Placebo, BMS-986278
Bristol-Myers Squibb
Pulmonary Fibrosis
08/22
09/23
NCT05684289: A Study Investigating the Safety, Tolerability, Drug Levels and Drug Effect of BMS-986278 in Healthy Adult Participants (Part 1) and Japanese Participants (Part 2)

Completed
1
61
US
BMS-986278, Sildenafil, Placebo
Bristol-Myers Squibb
Healthy Participants
05/23
05/23
NCT05805904: A Study to Evaluate the Drug Levels, Safety, and Tolerability of BMS-986278 in Healthy Chinese Participants

Completed
1
24
RoW
BMS-986278, Placebo
Bristol-Myers Squibb
Healthy Volunteers
05/23
05/23
NCT05932303: A Study to Assess the Effect of Multiple Doses of Itraconazole, Gemfibrozil, or Carbamazepine on BMS-986278 in Healthy Participants

Completed
1
47
Canada
BMS-986278, Itraconazole, Gemfibrozil, Carbamazepine
Bristol-Myers Squibb
Healthy Participants
10/23
10/23
NCT05985590: A Study to Investigate the Effects of BMS-986278 on Drospirenone and Ethinyl Estradiol Drug Levels in Healthy Female Participants

Completed
1
37
Canada
BMS-986278, Drospirenone/Ethinyl Estradiol
Bristol-Myers Squibb
Healthy Volunteers
12/23
12/23
NCT06425198: Study to Assess Drug Levels and Safety of BMS-986278 in Healthy Participants and Participants With Different Degrees of Hepatic Impairment

Recruiting
1
48
US
BMS-986278
Bristol-Myers Squibb
Hepatic Impairment, Healthy Participants
12/24
12/24
NCT06568458: A Study to Assess the Extent of Drug Interaction Between BMS-986278 and Nintedanib, the Relative Bioavailability of BMS-986278 in Tablet and the Effect That Food Has on BMS-986278 in Tablet Formulations in Healthy Participants

Completed
1
71
US
Nintedanib, BMS 986278
Bristol-Myers Squibb
Healthy Participants
02/25
02/25
NCT06723535: A Study to Evaluate BMS-986278 in Participants With Normal Renal Function, Severe Renal Impairment, or End-Stage Renal Disease on Intermittent Hemodialysis

Recruiting
1
32
US
BMS-986278
Bristol-Myers Squibb
Kidney Failure, Chronic, Healthy Volunteers, Renal Impairment
10/25
10/25
NCT06715683: A Study to Evaluate Comparative Bioavailability of BMS-986278 in Healthy Participants

Completed
1
48
US
BMS-986278 Batched method, Dose A, BMS-986278 Batched method, Dose B, BMS-986278 Continuous method
Bristol-Myers Squibb
Healthy Volunteers
03/25
03/25
NCT06746402: A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of BMS-986278 and the Effects of BMS-986278 on Cardiac Repolarization in Healthy Participants

Recruiting
1
42
US
BMS-986278, Placebo, Moxifloxacin
Bristol-Myers Squibb
Healthy Volunteers
09/25
09/25

Download Options